Literature DB >> 19398034

Functional roles of bestrophins in ocular epithelia.

Alan D Marmorstein1, Harold E Cross, Neal S Peachey.   

Abstract

There are four members of the bestrophin family of proteins in the human genome, of which two are known to be expressed in the eye. The gene BEST1 (formerly VMD2) which encodes the protein bestrophin-1 (Best1) was first identified in 1998. Mutations in this gene have now been associated with four clinically distinguishable human eye diseases, collectively referred to as "bestrophinopathies". Over the last decade, laboratories have sought to understand how Best1 mutations could result in eye diseases that range in presentation from macular degeneration to nanophthalmos. The majority of our knowledge comes from studies that have sought to understand how Best1 mutations or dysfunction could induce the classical symptoms of the most common of these diseases: Best vitelliform macular dystrophy (BVMD). BVMD is a dominant trait that is characterized electrophysiologically by a diminished electrooculogram light peak with a normal clinical electroretinogram. This together with the localization of Best1 to the retinal pigment epithelium (RPE) basolateral plasma membrane and data from heterologous expression studies, have led to the proposal that Best1 generates the light peak, and that bestrophins are a family of Ca(2+) activated Cl(-) channels (CaCCs). However, data from Best1 knock-out and knock-in mice, coupled with the recent discovery of a recessive bestrophinopathy suggest that Best1 does not generate the light peak. Recently Best2 was found to be expressed in non-pigmented epithelia in the ciliary body. However, aqueous dynamics in Best2 knock-out mice do not support a role for Best2 as a Cl(-) channel. Thus, the purported CaCC function of the bestrophins and how loss of this function relates to clinical disease needs to be reassessed. In this article, we examine data obtained from tissue-type and animal models and discuss the current state of bestrophin research, what roles Best1 and Best2 may play in ocular epithelia and ocular electrophysiology, and how perturbation of these functions may result in disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19398034      PMCID: PMC2740978          DOI: 10.1016/j.preteyeres.2009.04.004

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  180 in total

1.  Insertion and topology of normal and mutant bestrophin-1 in the endoplasmic reticulum membrane.

Authors:  Vladimir M Milenkovic; Andrea Rivera; Franziska Horling; Bernhard H F Weber
Journal:  J Biol Chem       Date:  2006-11-15       Impact factor: 5.157

2.  The bestrophin family of anion channels: identification of prokaryotic homologues.

Authors:  Andrew R Hagen; Ravi D Barabote; Milton H Saier
Journal:  Mol Membr Biol       Date:  2005 Jul-Aug       Impact factor: 2.857

Review 3.  Signaling by extracellular nucleotides.

Authors:  A J Brake; D Julius
Journal:  Annu Rev Cell Dev Biol       Date:  1996       Impact factor: 13.827

4.  The bestrophin mutation A243V, linked to adult-onset vitelliform macular dystrophy, impairs its chloride channel function.

Authors:  Kuai Yu; Yuanyuan Cui; H Criss Hartzell
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-11       Impact factor: 4.799

5.  Adrenergic receptor activated ion transport in human fetal retinal pigment epithelium.

Authors:  R H Quinn; J N Quong; S S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-01       Impact factor: 4.799

6.  Histopathology of Best's macular dystrophy.

Authors:  T A Weingeist; J L Kobrin; R C Watzke
Journal:  Arch Ophthalmol       Date:  1982-07

7.  Long-term evaluation of patients with Best's vitelliform dystrophy.

Authors:  C W Mohler; S L Fine
Journal:  Ophthalmology       Date:  1981-07       Impact factor: 12.079

Review 8.  Retinal oxygen: fundamental and clinical aspects.

Authors:  Norbert D Wangsa-Wirawan; Robert A Linsenmeier
Journal:  Arch Ophthalmol       Date:  2003-04

9.  The best disease-linked Cl- channel hBest1 regulates Ca V 1 (L-type) Ca2+ channels via src-homology-binding domains.

Authors:  Kuai Yu; Qinghuan Xiao; Guiying Cui; Amy Lee; H Criss Hartzell
Journal:  J Neurosci       Date:  2008-05-28       Impact factor: 6.167

10.  A novel mutation in the VMD2 gene in an Italian family with Best maculopathy.

Authors:  A Sodi; I Passerini; F Simonelli; F Testa; U Menchini; F Torricelli
Journal:  J Fr Ophtalmol       Date:  2007-06       Impact factor: 0.818

View more
  63 in total

1.  Multimodal fundus imaging in Best vitelliform macular dystrophy.

Authors:  Daniela C Ferrara; Rogério A Costa; Stephen Tsang; Daniela Calucci; Rodrigo Jorge; K Bailey Freund
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04-23       Impact factor: 3.117

Review 2.  Bestrophins and retinopathies.

Authors:  Qinghuan Xiao; H Criss Hartzell; Kuai Yu
Journal:  Pflugers Arch       Date:  2010-03-28       Impact factor: 3.657

Review 3.  The retinal pigment epithelium in health and disease.

Authors:  J R Sparrow; D Hicks; C P Hamel
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

4.  Quantitative Fundus Autofluorescence in Best Vitelliform Macular Dystrophy: RPE Lipofuscin is not Increased in Non-Lesion Areas of Retina.

Authors:  Janet R Sparrow; Tobias Duncker; Russell Woods; François C Delori
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 5.  Bestrophin 1 and retinal disease.

Authors:  Adiv A Johnson; Karina E Guziewicz; C Justin Lee; Ravi C Kalathur; Jose S Pulido; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Prog Retin Eye Res       Date:  2017-01-30       Impact factor: 21.198

Review 6.  Control of outflow resistance by soluble adenylyl cyclase.

Authors:  Yong Suk Lee; Alan D Marmorstein
Journal:  J Ocul Pharmacol Ther       Date:  2013-12-09       Impact factor: 2.671

Review 7.  BEST1: the Best Target for Gene and Cell Therapies.

Authors:  Tingting Yang; Sally Justus; Yao Li; Stephen H Tsang
Journal:  Mol Ther       Date:  2015-09-21       Impact factor: 11.454

8.  Suppression of Ca2+ signaling in a mouse model of Best disease.

Authors:  Youwen Zhang; J Brett Stanton; Jiang Wu; Kuai Yu; H Criss Hartzell; Neal S Peachey; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Hum Mol Genet       Date:  2010-01-06       Impact factor: 6.150

9.  BESTROPHIN1 mutations cause defective chloride conductance in patient stem cell-derived RPE.

Authors:  Yasmin Moshfegh; Gabriel Velez; Yao Li; Alexander G Bassuk; Vinit B Mahajan; Stephen H Tsang
Journal:  Hum Mol Genet       Date:  2016-05-18       Impact factor: 6.150

10.  Bestrophin 2 is expressed in human non-pigmented ciliary epithelium but not retinal pigment epithelium.

Authors:  Youwen Zhang; Rajkumar V Patil; Alan D Marmorstein
Journal:  Mol Vis       Date:  2010-02-10       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.